Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Replacement therapy for coronary artery bypass surgery in patients with hemophilia A and B.

Kanellopoulou T, Nomikou E.

J Card Surg. 2018 Feb;33(2):76-82. doi: 10.1111/jocs.13530. Epub 2018 Feb 13. Review.

PMID:
29439283
2.

How I manage patients with inherited haemophilia A and B and factor inhibitors.

Ljung RCR.

Br J Haematol. 2018 Feb;180(4):501-510. doi: 10.1111/bjh.15053. Epub 2017 Dec 22. Review.

PMID:
29270992
3.

Pharmacokinetic drug evaluation of recombinant factor VIII for the treatment of hemophilia A.

Castaman G, Linari S.

Expert Opin Drug Metab Toxicol. 2018 Feb;14(2):143-151. doi: 10.1080/17425255.2018.1420161. Epub 2017 Dec 27. Review.

PMID:
29257899
4.

Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A.

Raso S, Hermans C.

Expert Opin Biol Ther. 2018 Jan;18(1):87-94. doi: 10.1080/14712598.2018.1416088. Review.

PMID:
29256333
5.

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.

Rangarajan S, Walsh L, Lester W, Perry D, Madan B, Laffan M, Yu H, Vettermann C, Pierce GF, Wong WY, Pasi KJ.

N Engl J Med. 2017 Dec 28;377(26):2519-2530. doi: 10.1056/NEJMoa1708483. Epub 2017 Dec 9.

PMID:
29224506
6.

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.

George LA, Sullivan SK, Giermasz A, Rasko JEJ, Samelson-Jones BJ, Ducore J, Cuker A, Sullivan LM, Majumdar S, Teitel J, McGuinn CE, Ragni MV, Luk AY, Hui D, Wright JF, Chen Y, Liu Y, Wachtel K, Winters A, Tiefenbacher S, Arruda VR, van der Loo JCM, Zelenaia O, Takefman D, Carr ME, Couto LB, Anguela XM, High KA.

N Engl J Med. 2017 Dec 7;377(23):2215-2227. doi: 10.1056/NEJMoa1708538.

PMID:
29211678
7.

Trenonacog alfa for prophylaxis, on-demand and perioperative management of hemophilia B.

Brennan Y, Curnow J, Favaloro EJ.

Expert Opin Biol Ther. 2018 Jan;18(1):95-100. doi: 10.1080/14712598.2018.1407311. Epub 2017 Nov 26. Review.

PMID:
29172774
8.

Management of Hemophilia in Older Patients.

Franchini M, Mannucci PM.

Drugs Aging. 2017 Dec;34(12):881-889. doi: 10.1007/s40266-017-0500-8. Review.

PMID:
29159733
9.

Open repair of intraoperative popliteal artery injury during total knee arthroplasty in a patient with severe hemophilia A: A case report and literature review.

Feng B, Xiao K, Shao J, Fan Y, Weng X.

Medicine (Baltimore). 2017 Nov;96(46):e8791. doi: 10.1097/MD.0000000000008791. Review.

10.

Gene therapy for hemophilia.

Pipe SW.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26865. Epub 2017 Oct 27. Review.

PMID:
29077262
11.

Simoctocog alfa for the treatment of hemophilia A.

Morfini M.

Expert Opin Biol Ther. 2017 Dec;17(12):1573-1580. doi: 10.1080/14712598.2017.1391785. Epub 2017 Oct 20. Review.

PMID:
29050497
12.

Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.

Uemura H, Tsukada K, Mizushima D, Aoki T, Watanabe K, Kinai E, Teruya K, Gatanaga H, Kikuchi Y, Sugiyama M, Mizokami M, Oka S.

PLoS One. 2017 Oct 18;12(10):e0186255. doi: 10.1371/journal.pone.0186255. eCollection 2017.

13.

Novel approaches to hemophilia therapy: successes and challenges.

Arruda VR, Doshi BS, Samelson-Jones BJ.

Blood. 2017 Nov 23;130(21):2251-2256. doi: 10.1182/blood-2017-08-742312. Epub 2017 Oct 10. Review.

PMID:
29018078
14.

The benefit of low dose prophylaxis in the treatment of hemophilia: a focus on China.

Wu R, Luke KH.

Expert Rev Hematol. 2017 Nov;10(11):995-1004. doi: 10.1080/17474086.2017.1386096. Epub 2017 Oct 25. Review.

PMID:
28971697
15.

Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.

Chai-Adisaksopha C, Nevitt SJ, Simpson ML, Janbain M, Konkle BA.

Cochrane Database Syst Rev. 2017 Sep 25;9:CD011441. doi: 10.1002/14651858.CD011441.pub2. Review.

PMID:
28944952
16.

Fibrin glue for local haemostasis in haemophilia surgery.

Rodriguez-Merchan EC.

Hosp Pract (1995). 2017 Dec;45(5):187-191. doi: 10.1080/21548331.2017.1384689. Epub 2017 Oct 3. Review.

PMID:
28942686
17.

Gene Therapy for Hemophilia.

Nathwani AC, Davidoff AM, Tuddenham EGD.

Hematol Oncol Clin North Am. 2017 Oct;31(5):853-868. doi: 10.1016/j.hoc.2017.06.011. Review.

PMID:
28895852
19.

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis.

Rosendaal FR, Palla R, Garagiola I, Mannucci PM, Peyvandi F; SIPPET Study Group.

Blood. 2017 Oct 12;130(15):1757-1759. doi: 10.1182/blood-2017-06-791756. Epub 2017 Aug 2.

PMID:
28768627
20.

Efficacy of standard prophylaxis versus on-demand treatment with bayer's sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with severe hemophilia A.

Zhao Y, Xiao J, Yang R, Wu R, Hu Y, Beckmann H, Wu J, Hou Q, Sun J.

Pediatr Hematol Oncol. 2017 Apr;34(3):138-148. doi: 10.1080/08880018.2017.1313921. Epub 2017 Jul 20.

PMID:
28727494

Supplemental Content

Loading ...
Support Center